Oncology Institute (TOI) Revenue (2021 - 2026)

Oncology Institute (TOI) has reported Revenue for 6 consecutive years, with $147.4 million the latest figure, recorded in Q1 2026.

• Revenue for Q1 2026 came in at $147.4 million, up 41.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $545.8 million (up 35.37% YoY), and the FY2025 annual result was $502.7 million, up 27.79% from the prior year.
• Revenue was $147.4 million for Q1 2026 at Oncology Institute, up from $142.0 million in the prior quarter.
• Over five years, Revenue peaked at $147.4 million in Q1 2026 and troughed at $55.2 million in Q1 2022.
• Average Revenue over 5 years is $95.3 million, with a median of $94.7 million recorded in 2024.
• The widest YoY moves for Revenue: up 41.58% in 2025, down 10.29% in 2025.
• Over 5 years, Revenue stood at $71.4 million in 2022, then increased by 20.11% to $85.8 million in 2023, then increased by 16.88% to $100.3 million in 2024, then surged by 41.58% to $142.0 million in 2025, then gained by 3.86% to $147.4 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $147.4 million in Q1 2026, $142.0 million in Q4 2025, and $136.6 million in Q3 2025.